All financings
COMPANY TRANSACTIONS

Polyrizon Ltd.

PLRZNasdaqBiotechnology

Deal details

1 transaction in the database

TRANSACTION REPORT · SEC DISCLOSURES
Gross proceeds$4.0M
Offering price$12.00
Discount to prior close4.1%
Warrant coverage100%
Placement agent / underwriterAegis Capital Corp.

Transaction overview

01

Polyrizon Ltd. completed a $4.0M registered direct at $12.00 per share. Aegis Capital Corp. acted as exclusive placement agent for the financing.

Financing type
Registered Direct
Announcement date
Sep 3, 2026
Pricing date
Sep 3, 2026
Closing date
Sep 4, 2026
Filing date
Sep 4, 2026
Status
Closed
Market cap before announcement
$20.1M
Prior closing price
$12.51
Raise as % of market cap
19.9%

Market data · FMP

Historical market cap
$20,119,407
Market date
Sep 2, 2026
Closing price
$12.51
Latest reported shares outstanding
1,120,210
Latest reported float shares
1,051,470
Share-data date
Sep 29, 2026

Market cap and closing price are from FMP for the date shown. Shares are FMP’s latest available snapshot, dated separately. Updated Sep 30, 2026.

Financial Modeling Prep ↗

Financing terms

02

Equity

Common shares issued
232,500
Price per share
$12.00
Pre-funded warrants
100,833
Pre-financing shares disclosed in filing
—
Shares outstanding after financing
—

Investor warrants

Warrant shares
333,333
Cash exercise price
$12.00
Term
Five years from issuance; immediately exercisable
Initial exercisability
—
Beneficial ownership limits
—

Fees & transaction economics

03
Placement agent / underwriting fee
8%
Agent fee amount
$320,000
Management fee
—
Other offering expenses (estimated)
—
Net proceeds (estimated)
—
Net proceeds as % of gross
—

Fee amounts reflect disclosed inputs. Unknown expense components are not assumed to be zero.

Registered direct and concurrent private placement; combined gross proceeds and combined pre-funded count. Placement fee 8% per disclosed engagement; future warrant exercise proceeds excluded.

Transaction participants

04
Investor names: —

Source documents

05

SEC filings, exhibits and attributed market data. The report separates disclosed facts, calculated metrics, and unknown terms.

424B5 · Polyrizon Ltd.SEC filing · Sep 4, 2026
Open source ↗
6-K · Polyrizon Ltd.SEC filing · Sep 4, 2026
Open source ↗
EX-10.1 · Polyrizon Ltd.SEC filing · Sep 4, 2026
Open source ↗
EX-10.2 · Polyrizon Ltd.SEC filing · Sep 4, 2026
Open source ↗
EX-10.3 · Polyrizon Ltd.SEC filing · Sep 4, 2026
Open source ↗
EX-10.4 · Polyrizon Ltd.SEC filing · Sep 4, 2026
Open source ↗
EX-10.5 · Polyrizon Ltd.SEC filing · Sep 4, 2026
Open source ↗
EX-10.6 · Polyrizon Ltd.SEC filing · Sep 4, 2026
Open source ↗
EX-5.1 · Polyrizon Ltd.SEC filing · Sep 4, 2026
Open source ↗
EX-5.2 · Polyrizon Ltd.SEC filing · Sep 4, 2026
Open source ↗
EX-99.1 · Polyrizon Ltd.SEC filing · Sep 4, 2026
Open source ↗
6-K · Polyrizon Ltd.SEC filing · Sep 4, 2026
Open source ↗
EX-99.1 · Polyrizon Ltd.SEC filing · Sep 4, 2026
Open source ↗
FMP historical market data · PLRZMarket data · Sep 2, 2026
Open source ↗
SEC deal terms · FMP market data where available · Initial research sample, not complete market coverage. AI-assisted source review; original evidence is available in each report. Names and tickers reflect the transaction date. A dash (—) means the value is unavailable.